How did Moody's downgrade affect U.S. markets?
What impact will 23andMe sale have on genetic data privacy?
Why is Canada Post facing a potential postal strike?
How will Trump's tariffs influence U.S. housing market?
Why is JPMorgan allowing clients to buy Bitcoin now?
What caused the recent dip in Tesla's stock price?
How is AI changing job roles according to Indeed CEO?
Why are mortgage rates rising above 7%?
How will EU-UK post-Brexit reset affect trade?
Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal
benzinga.com/general/biotech/25/05/45504107/genetic-data-from-23andme-ends-up-with-this-company-in-256-million-deal
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction for key assets of 23andMe Holding Co. in a $256 million deal to boost its genetics-based drug discovery efforts.
The acquisition includes 23andMe’s Personal Genome…
This story appeared on benzinga.com, 2025-05-19 19:29:24.